Georgetown University Medical Centre - Articles and news items

Resveratrol stabilises Alzheimer’s disease biomarker

Industry news / 14 September 2015 / Victoria White

Patients who were treated with increasing doses of resveratrol over 12 months showed little or no change in amyloid-beta40 (Abeta40) levels…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+